HIGH

Medtronic MiniMed 720G Insulin Pump Recall 2026 Affects 37,458 Units Worldwide

Medtronic MiniMed recalled 37,458 insulin pumps sold worldwide through healthcare providers, including the MiniMed 720G, after finding that a pump raised above or lowered relative to the infusion site can deliver insulin too much or too little. The defect stems from changes in gravitational force affecting hydrostatic and hydrodynamic pressures at the infusion site. Patients should stop using the

Quick Facts at a Glance

Recall Date
February 13, 2026
Hazard Level
HIGH
Brand
Medtronic MiniMed
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Medtronic MiniMed, Inc. or your healthcare provider for instructions. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

The MiniMed insulin pump is an automated device that delivers insulin through a catheter to manage diabetes. It is used by both adults and children under medical supervision.

Why This Is Dangerous

The pump’s delivery can be disrupted by gravity when the device is higher or lower than the infusion site, altering insulin delivery in real time and potentially causing dangerous glucose fluctuations.

Industry Context

This recall is not described as part of a broader pattern in the provided data.

Real-World Impact

Consumers must halt use immediately to avoid life-threatening hypoglycemia or diabetic ketoacidosis. The recall has global reach and requires action by patients and healthcare providers.

Practical Guidance

How to identify if yours is affected

  1. Identify if your pump is Paradigm series, 600 series, or BLE 700 series, including MiniMed 720G.
  2. Check model identifiers and GTINs listed in the recall documentation.
  3. Compare device serial numbers and packaging labels to recall data.

Where to find product info

Recall instructions and recipient contact details are on the FDA recall page linked in this dataset.

What timeline to expect

Refund or replacement processing typically 4-8 weeks after eligibility is confirmed.

If the manufacturer is unresponsive

  • Escalate to your healthcare provider for guidance.
  • File a formal complaint with Medtronic MiniMed and document all communications.

How to prevent similar issues

  • When buying diabetes management devices, verify the model number and GTIN against recall lists.
  • Verify device calibration and site placement documentation with your clinician.

Documentation advice

Keep copies of recall notices, model numbers, serials, dates, and all correspondence with Medtronic or your provider.

Product Details

Product: MiniMed 720G Insulin Pump. Model numbers include MMT-1809, MMT-1810, MMT-1859, MMT-1860, MMT-1867. Sold worldwide through healthcare providers and medical supply channels. Sold since: Unknown. Price: Unknown. Distribution: Worldwide.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 37,458 units recalled worldwide
  • Affects MiniMed 720G and older Paradigm, 600 series, BLE 700 series pumps
  • Hazard: unintended insulin delivery due to pump height relative to infusion site
  • Over-delivery can cause severe hypoglycemia and death; under-delivery can cause severe hyperglycemia
  • Distribution includes worldwide, with U.S. states listed in the recall notice

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
9/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
Pump: UDI-DI(GTIN): User Guide Name(Part-Version): MiniMed 720G Insulin Pump: 763000854768
763000505196
763000505219
763000505318
763000505257
+15 more
Affected States
ALL
Report Date
April 8, 2026
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
HIGH

Medtronic MiniMed 780G Insulin Pump Recalled for 453,144 Units Worldwide (2026)

Medtronic recalled 453,144 MiniMed 780G insulin pumps worldwide after reports of unintended insulin delivery when the pump height changes relative to the infusion site. The defect stems from gravity-driven pressure changes affecting hydrostatic delivery. Patients and caregivers should stop using the devices immediately and follow the recall notice, contacting Medtronic MiniMed or their clinician’s

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH

Medtronic MiniMed 740G Insulin Pump Recalled for 24,946 Units Worldwide (2026)

Medtronic MiniMed recalled 24,946 MiniMed 740G insulin pumps worldwide after identifying unintended insulin delivery when the pump height changes relative to the infusion site. The defect can cause over-delivery or under-delivery of insulin due to gravity-driven pressure changes. Patients should stop using the device and contact Medtronic MiniMed for instructions on recall steps, refunds or a swap

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH

Medtronic MiniMed Paradigm Revel Insulin Pumps Recalled: 26,647 Units Worldwide (2026)

Medtronic MiniMed recalled 26,647 Paradigm REAL-Time Revel insulin pumps distributed worldwide, including in the United States. A design flaw can cause insulin to be over- or under-delivered when the pump height changes relative to the infusion site. Patients and health providers should stop using the device immediately and follow the manufacturer’s recall instructions. The recall covers Paradigm,

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH

Medtronic MiniMed Paradigm Veo Insulin Pump Recalled for 55,724 Units (2026)

Medtronic MiniMed recalls 55,724 Paradigm REAL-Time Veo insulin pumps distributed worldwide. The pumps can deliver too much insulin when raised or too little when lowered relative to the infusion site due to gravity-driven pressure changes. Patients should stop using the device and contact Medtronic MiniMed or their healthcare provider for instructions and refunds.

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH

Medtronic MiniMed Paradigm Real-Time Insulin Pump Recalled for 29,074 Units Worldwide (2026)

Medtronic MiniMed recalled 29,074 Paradigm Real-Time insulin pumps worldwide. The devices may deliver insulin improperly when the pump is elevated or lowered relative to the infusion site due to gravitational effects. Patients should stop using the pumps immediately and follow recall instructions from the manufacturer and their healthcare provider.

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH

Medtronic MiniMed Paradigm Insulin Pumps Recalled 73,656 Units Worldwide in 2026

Medtronic MiniMed recalled 73,656 Paradigm insulin pumps sold worldwide, including broad U.S. distribution, after a risk of unintended insulin delivery. The issue affects Paradigm, 600-series and BLE 700-series pumps. It can cause life-threatening highs or lows in insulin delivery. Stop using the device and follow recall instructions immediately.

Medtronic MiniMed
All Medtronic
Read more
Health & Personal Care
HIGH

Medtronic MiniMed 630G Insulin Pumps Recalled in 2026 for Insulin Delivery Errors (60,880 Units)

Medtronic MiniMed recalled 60,880 insulin pumps sold worldwide through healthcare providers and medical distributors, including the MiniMed 630G line. The defect is gravity related and can cause insulin over-delivery or under-delivery when the pump height changes relative to the infusion site. Patients should stop using the pumps immediately and follow recall instructions.

Medtronic MiniMed
All Medtronic
Read more